Pancragen

Pancragen is a Khavinson short-peptide bioregulator (Lys-Glu-Asp-Trp / KEDW) originally isolated from pancreatic tissue extracts in Russian gerontology research. It has been studied in animal and cell-culture models for islet-cell function, glucose-handling parameters, and pancreatic tissue ageing, alongside other organ-targeted Khavinson tetrapeptides such as Livagen (liver) and Cortagen (cerebral cortex). Sold by research-peptide vendors at 5–20 mg vial sizes for laboratory work; not approved by FDA, MHRA, Health Canada, or TGA for human use. Research-use only — Pepticker does not provide medical advice and this entry summarises published preclinical research, not a dosing protocol.

Also known as: Pancreatic bioregulator, KEDW